The present report describes a rare case of esophageal carcinoid tumor that was treated by endoscopic resection. A 43-year-old woman underwent esophagogastroduodenoscopy at her family clinic for screening of the upper digestive tract and a small lesion resembling a submucosal tumor was detected in the lower esophagus. A biopsy sample from the lesion was diagnosed as esophageal carcinoid tumor and the patient visited our hospital for detailed examination. The tumor was approximately 3 mm in diameter and its surface appeared to be covered with normal squamous epithelium. The tumor had a shiny reddish surface without ulceration or erosion. Magnifying endoscopy with narrow-band imaging showed structures resembling reticular vessels under the epithelium. Endoscopic ultrasonography depicted the tumor as a low-echoic mass within the lamina propria. Computed tomography did not detect the tumor and no metastatic lesions were evident in other organs. With the patient's informed consent, the tumor was resected using endoscopic submucosal dissection, with a sufficient free margin in both the vertical and horizontal directions. Magnifying endoscopic examination showed the resected tumor to have abundant reticular vessels. Finally, the tumor was diagnosed immunopathologically as an esophageal carcinoid tumor (neuroendocrine cell tumor, grade 1), without lymphatic or vascular invasion.

Download full-text PDF

Source
http://dx.doi.org/10.1111/den.12385DOI Listing

Publication Analysis

Top Keywords

esophageal carcinoid
16
carcinoid tumor
16
tumor
13
tumor treated
8
treated endoscopic
8
endoscopic resection
8
reticular vessels
8
endoscopic
5
esophageal
4
resection report
4

Similar Publications

Introduction: Choroidal metastases from systemic malignancies are the most common intraocular malignancies in adults. External beam radiation (EBR) has historically been first-line therapy for metastatic tumors to the choroid. However, good responses have been described with newer targeted biologics.

View Article and Find Full Text PDF

Autoimmune Atrophic Gastritis: A Clinical Review.

Cancers (Basel)

March 2024

Department of Medical Sciences and Surgery, University of Bologna, 40138 Bologna, Italy.

Autoimmune atrophic gastritis (AAG) is a chronic condition characterized by the presence of atrophy in the oxyntic mucosa due to anti-parietal cell antibodies. This review provides a comprehensive and up-to-date overview of autoimmune atrophic gastritis, reporting recent evidence on epidemiology, pathogenesis, diagnosis, clinical presentation, risk of malignancies, and management. The prevalence of AAG has been estimated at between 0.

View Article and Find Full Text PDF

Neuroendocrine tumors (NETs) are rare and slow-growing. They are often found incidentally, and patients typically present with vague symptoms. This is a case report detailing an 83-year-old female who presents with signs and symptoms consistent with esophageal stricture and was incidentally found to have a duodenal NET.

View Article and Find Full Text PDF

Background: Proton pump inhibitors (PPIs) are one of the most used classes of drugs. For most indications, PPIs are only recommended up to 8 weeks duration. However, PPI use continues to expand.

View Article and Find Full Text PDF
Article Synopsis
  • The VISION study was a phase 4 clinical trial conducted in Japan to evaluate the long-term safety of vonoprazan compared to lansoprazole for patients with healed erosive oesophagitis.
  • Patients were initially treated for healing and then entered a 260-week maintenance phase, with the primary focus on changes in gastric mucosal histopathology.
  • Results showed that while hyperplasia of certain gastric cells was more common with vonoprazan, no significant safety issues arose, and no neoplastic changes were observed in either treatment group over three years.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!